卵巢-附件报告与数据系统、IOTA简单规则及儿童恶性风险指数对儿童附件病变的诊断准确性:比较研究
单中心回顾性诊断准确性研究纳入中国一家三级医院2015年1月至2024年1月连续收治的≤17岁附件病变患者364例共375个病变,恶性率2.1%(8/375)。O-RADS、IOTA两步策略和PRMI的AUC分别为0.989、0.992和0.806;IOTA两步策略准确性最高,在1%至30%恶性风险阈值区间净获益最大。作者认为O-RADS和IOTA两步策略在儿童附件病变中诊断准确性高、与成人相当,PRMI鉴别能力较低,不推荐作为独立诊断工具。
要点
- 儿童附件病变恶性率低(2.1%,8/375),O-RADS与IOTA两步策略AUC均≥0.989,诊断准确性高。
- IOTA两步策略(简单规则后对不确定病例行专家评估)在1%–30%恶性风险阈值区间净获益最大。
- PRMI的AUC为0.806,鉴别能力低于O-RADS和IOTA两步策略,作者不推荐其作为独立诊断工具。
核心结论
- 在该回顾性儿童队列中,O-RADS超声模型与IOTA简单规则后对不确定病例行专家评估的两步策略对附件病变定性诊断准确性高,与成人中观察到的结果相当。
- 上述结果支持将这两种风险分层方法应用于儿童人群。
- PRMI评分系统鉴别能力低于其他模型,因此不推荐其作为独立诊断工具。
研究设计与样本
- 单中心回顾性诊断准确性研究,在中国一家三级医院开展。
- 连续纳入2015年1月至2024年1月接受手术或保守管理的≤17岁附件病变患者364例、共375个病变。
- 每个病变分别用O-RADS超声风险分层与管理工具、IOTA简单规则(对不确定病例序贯专家评估的两步策略)和PRMI模型评估。
- 参考标准为手术干预或保守管理联合超声随访。
- 采用AUC、敏感度、特异度、阳性预测值和阴性预测值评价准确性,并用决策曲线分析评价临床效用。
诊断标准与关键数值
- O-RADS工具的AUC为0.989(95%CI 0.980–0.999)。
- IOTA两步策略的AUC为0.992(95%CI 0.985–0.998)。
- PRMI模型的AUC为0.806(95%CI 0.626–0.985)。
- IOTA两步策略准确性最高,在1%至30%恶性风险阈值区间内相比其他两种模型提供最大净获益。
- 队列恶性率为2.1%(8/375),患者中位年龄15.0岁(四分位距14.0–17.0岁)。
临床应用与阅片要点
- 作者认为O-RADS超声模型和IOTA两步策略可用于儿童附件病变的风险分层。
- 作者不推荐PRMI评分系统作为独立诊断工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Many risk stratification models have been developed to improve the accuracy of sonographic evaluation of adnexal lesions. Although these models have been validated across various adult populations, their accuracy in the pediatric population remains underexplored. This study aimed to evaluate and compare the diagnostic accuracy of three sonography-based risk models in assessing pediatric adnexal lesions.
METHODS: This was a single-center retrospective diagnostic accuracy study conducted at a tertiary hospital in China, which included consecutive patients aged 17 years or younger with adnexal lesions managed either surgically or conservatively between January 2015 and January 2024. Each adnexal lesion was assessed using the Ovarian-Adnexal Reporting and Data System (O-RADS) ultrasound risk stratification and management tool, the International Ovarian Tumor Analysis (IOTA) Simple Rules (SR) followed by expert assessment for inconclusive cases in a two-step strategy and the Pediatric Risk of Malignancy Index (PRMI) model. The reference standard was either surgical intervention or conservative management with ultrasound surveillance. The accuracy of the different sonography-based risk models was evaluated using the area under the receiver-operating-characteristics curve (AUC), sensitivity, specificity and positive and negative predictive values. The clinical utility of each model was evaluated using decision-curve analysis.
RESULTS: This study included 364 patients with a total of 375 adnexal lesions. The median age of the patients was 15.0 (interquartile range, 14.0-17.0) years, with a malignancy rate of 2.1% (8/375). The AUC for the O-RADS tool, IOTA two-step strategy and the PRMI model were 0.989 (95% CI, 0.980-0.999), 0.992 (95% CI, 0.985-0.998) and 0.806 (95% CI, 0.626-0.985), respectively. The IOTA two-step strategy demonstrated the highest accuracy and provided the greatest net benefits at malignancy risk thresholds between 1% and 30% compared with the other two models.
CONCLUSIONS: In this retrospective pediatric cohort, the O-RADS ultrasound model and the IOTA-SR followed by expert assessment for inconclusive cases in a two-step strategy exhibited high diagnostic accuracy in characterizing adnexal lesions, comparable to that observed in adults. These results support the applicability of both of these risk-stratification methods to the pediatric population. The PRMI scoring system showed lower discriminative capacity compared with the other models; therefore, it is not recommended to serve as a standalone diagnostic tool. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Wu M, Huang L, Chen Y, et al. Diagnostic accuracy of Ovarian-Adnexal Reporting and Data System, IOTA Simple Rules and Pediatric Risk of Malignancy Index for pediatric adnexal lesions: comparative study. Ultrasound Obstet Gynecol. 2025. PMID: 40643593. doi:10.1002/uog.29291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。